Keyphrases
Community-onset
100%
Titer
100%
Staphylococcus Aureus
100%
Protective Immunity
100%
Serologic
100%
Staphylococcal Infections
100%
Humoral Response
66%
Panton-Valentine Leukocidin
66%
Cutaneous Infection
66%
S. Aureus Infection
66%
Convalescent
66%
Infection Risk
33%
Virulence Factors
33%
Infectious Diseases
33%
Very Virulent
33%
Disease Pathogenesis
33%
Premier
33%
Human Infection
33%
Recurrent Disease
33%
Skin Tissue
33%
Soft Tissue Infection
33%
Drug Resistance
33%
Recurrent Infection
33%
Invasive Disease
33%
S. Aureus Colonization
33%
Clinical Trial Design
33%
Human Population
33%
Protective Immune Response
33%
Invasive Infection
33%
Virulent Strain
33%
Convalescent Serum
33%
Resistance Emergence
33%
Serological Response
33%
Hemolysin
33%
Staphylococcal Enterotoxins
33%
Subsequent Infection
33%
Serum Antibody Levels
33%
Strategic Development
33%
LukS-PV
33%
Medicine and Dentistry
Staphylococcus Aureus
100%
Staphylococcus Infection
100%
Infection
83%
Disease
33%
Immunotherapy
33%
Skin Infection
33%
Panton Valentine Leukocidin
33%
Humoral Immunity
33%
Clinical Trial
16%
Immune Response
16%
Drug Resistance
16%
Recurrent Disease
16%
Virulence Factor
16%
Recurrent Infection
16%
Exotoxin
16%
Soft Tissue Infection
16%
Hemolysin
16%
Pathogenic Organism
16%
Pharmacology, Toxicology and Pharmaceutical Science
Staphylococcus Aureus
100%
Staphylococcal Infection
100%
Infection
83%
Disease
33%
Immunotherapy
33%
Panton-Valentine Leukocidin
33%
Skin Infection
33%
Clinical Trial
16%
Recurrent Disease
16%
Virulence Factor
16%
Soft Tissue Infection
16%
Drug Resistance
16%
Recurrent Infection
16%
Hemolysin
16%
Exotoxin
16%
Immunology and Microbiology
Staphylococcus Aureus
100%
Titer
42%
Immunotherapy
28%
Humoral Immunity
28%
Drug Resistance
14%
Immune Response
14%
Virulence Factor
14%
Soft Tissue
14%
Antibody Blood Level
14%
Hemolysin
14%
Immunology
14%
Exotoxin
14%